Immunic, INC. (IMUX) — DEF 14A Filings

All DEF 14A filings from Immunic, INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (3)

Immuno, Inc. Files Definitive Proxy Statement for 2025 Annual Meeting — Apr 22, 2025 Risk: low
Immuno, Inc. filed its definitive proxy statement on April 22, 2025, for its annual meeting of stockholders scheduled for June 4, 2025. The filing outlines the
Immunic, Inc. Announces Annual Stockholder Meeting on June 11, 2024 — Apr 23, 2024 Risk:
IMMUNIC, INC. (IMUX) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Immunic, Inc. will hold its annual meeting of stockholders on June 11, 20
Immunic, Inc. Announces Special Meeting of Stockholders on March 4, 2024 — Feb 5, 2024 Risk: low
IMMUNIC, INC. (IMUX) filed a Proxy Statement (DEF 14A) with the SEC on February 5, 2024. Immunic, Inc. is holding a special meeting of stockholders on March 4,

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX